CXCR4 Antibody Blocking Peptide
Novus Biologicals | Catalog # NB100-56437PEP
Loading...
Loading...
Product Specifications
Application Notes
This peptide is useful as a blocking peptide for NB100-56437. For further blocking peptide related protocol, click here.
Specificity
This peptide is specific for NB100-56437 only.
Protein / Peptide Type
Antibody Blocking Peptide
Formulation, Preparation, and Storage
NB100-56437PEP
| Formulation | Peptide dissolved in dH20. Contains no BSA. |
| Preservative | No Preservative |
| Concentration | 1 mg/ml |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Store at -80C. Avoid freeze-thaw cycles. |
Background: CXCR4
Long Name
C-X-C Motif Chemokine Receptor 4
Alternate Names
CD184, D2S201E, FB22, Fusin, HM89, HSY3RR, LAP-3, LAP3, LCR1, LESTR, NPY3R, NPYRL, NPYY3R, WHIMS
Gene Symbol
CXCR4
Additional CXCR4 Products
Product Documents for CXCR4 Antibody Blocking Peptide
Product Specific Notices for CXCR4 Antibody Blocking Peptide
This product is for research use only and is not approved for use in humans or in clinical diagnosis. This product is guaranteed for 1 year from date of receipt.
Related Research Areas
Customer Reviews for CXCR4 Antibody Blocking Peptide
There are currently no reviews for this product. Be the first to review CXCR4 Antibody Blocking Peptide and earn rewards!
Have you used CXCR4 Antibody Blocking Peptide?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 Yen for a review with an image
$10/€7/£6/$10CAN/¥1110 Yen for a review without an image
Submit a review
FAQs for CXCR4 Antibody Blocking Peptide
Showing
1
-
1 of
1 FAQ
Showing All
-
Q: Which is your best CXCR4 for immunohistochemistry in paraffin tissues? I would like to detect it in paraffin embedded tissues from human breast cancer samples.
A: CXCR4 antibody (NB100-74396) is our best selling product among all the CXCR4 antibodies and it has been validated for IHC-P in human cervical carcinoma tissue sections. NB100-74396 has been cited in at least 7 research publications. Additionally, here is a list of all of our CXCR4 antibodies that has been verified in IHC-P in human samples.